ReviewThe EMBO journal2026
Human immunosuppressive neutrophils: recent answers to old and new questions.
Review in The EMBO journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Polymorphonuclear myeloid-derived suppressor cells (PMN-MDSCs) represent the most investigated type of "immunosuppressive" neutrophils in humans. However, a detailed understanding of human PMN-MDSCs has been hindered for years by limited knowledge of their specific markers for sorting and purification, as well as by their very low numbers in patient circulation. Recently, the use of advanced technologies has shown that human PMN-MDSCs are generated during emergency granulopoiesis and comprise a heterogeneous population of both immature and mature neutrophils. It has also been shown that human mature PMN-MDSCs (mPMN-MDSCs) perform immunosuppressive functions through transcriptional reprogramming during maturation. Furthermore, single-cell RNA sequencing experiments have shown that human mPMN-MDSCs and tumor-associated neutrophils (TANs) share transcriptomic similarities, therefore uncovering a potential relationship between them. In this Perspective, we discuss: i) how our knowledge on human PMN-MDSCs has advanced; ii) the criteria for discriminating human PMN-MDSCs from normal neutrophils or other immunosuppressive neutrophil populations; iii) recent findings revealing that human mPMN-MDSCs exhibit transcriptomic features suggestive of functions beyond immunosuppression.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.